Cargando…
Migraine day frequency in migraine prevention: longitudinal modelling approaches
BACKGROUND: Health economic models are critical tools to inform reimbursement agencies on health care interventions. Many clinical trials report outcomes using the frequency of an event over a set period of time, for example, the primary efficacy outcome in most clinical trials of migraine preventio...
Autores principales: | Di Tanna, Gian Luca, Porter, Joshua K., Lipton, Richard B., Brennan, Alan, Palmer, Stephen, Hatswell, Anthony J., Sapra, Sandhya, Villa, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343253/ https://www.ncbi.nlm.nih.gov/pubmed/30674285 http://dx.doi.org/10.1186/s12874-019-0664-5 |
Ejemplares similares
-
Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials
por: Di Tanna, Gian Luca, et al.
Publicado: (2019) -
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials
por: Porter, Joshua K., et al.
Publicado: (2018) -
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
por: Mannix, Sally, et al.
Publicado: (2016) -
Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine
por: Buse, Dawn C., et al.
Publicado: (2020) -
Fremanezumab for preventive treatment of migraine: Functional status on headache-free days
por: VanderPluym, Juliana, et al.
Publicado: (2018)